R84.2
Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code R84.2 refers to findings of abnormal levels of various drugs, medications, or biological substances in samples taken from the respiratory organs and thorax. This code helps healthcare professionals document and investigate unusual chemical presence in respiratory specimens, which can be vital for diagnosing certain conditions, monitoring drug therapy, or identifying exposure to harmful substances. While it doesn't specify a disease on its own, this code highlights an abnormal lab result that warrants further examination and consideration within a broader clinical context.
Causes & Symptoms
Clinical Causes: Medication overdose or accumulation Inappropriate drug metabolism or clearance Exposure to environmental or occupational toxins Use of experimental or investigational drugs Laboratory contamination or testing errors Underlying metabolic disorder affecting drug processing Therapeutic drug monitoring for medication adjustment
Key Symptoms: Respiratory discomfort or difficulty breathing (if related to toxicity) Signs of allergic reactions or hypersensitivity Unexplained cough or chest discomfort Symptoms related to drug side effects such as fatigue or dizziness Laboratory findings indicating abnormal biological substances in respiratory samples
Diagnostic & Treatment
Diagnosis Path: To identify abnormal levels of drugs or biological substances, healthcare providers typically utilize laboratory testing such as sample analysis from respiratory secretions, sputum, or bronchoalveolar lavage fluid. These tests measure chemical concentrations and compare them to established normal ranges. Diagnostic steps may also include reviewing patient medication history, environmental exposures, and performing additional imaging or clinical assessments to evaluate potential causes of abnormal findings.
Treatment Protocols: Addressing abnormal drug levels detected in respiratory specimens depends on the underlying cause. Management strategies may involve adjusting medication dosages, discontinuing certain drugs, treating any associated toxicity or reaction, and addressing environmental exposures. Close collaboration between healthcare providers and laboratory specialists ensures appropriate follow-up and necessary interventions to stabilize the patient's condition. Importantly, treating the root cause is essential for resolving the abnormal laboratory findings.
Clinical Advice & FAQs
Billing Guidance
Is R84.2 a billable ICD-10 code?
Yes, R84.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R84.2?
Clinical documentation must specify the nature of Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax and any associated comorbidities for accurate reporting.
Cite this Clinical Reference